drugset / Trial / NCT00768183

Comparison of KADIAN 100 mg When Dosed With Alcohol Under Fasting and Fed Conditions Compared to Water

NCT00768183

Phase 1 Completed 32 enrolled Actavis Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

The objective of this study was to compare the single-dose relative bioavailability of Alpharma Branded Products Division Inc. (KADIAN) 100 mg morphine sulfate extended-release capsules when dosed with alcohol under fasting and fed conditions compared to water.

Timeline

Start
2006-05
Primary completion
2006-07
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Alcohol Other / unclassified 240 ml Oral
Subject Morphine Other / unclassified 20 mg Oral
Subject Morphine Other / unclassified 100 mg Oral

Indications

No indication recorded.